Intrinsic Value of S&P & Nasdaq Contact Us

KORU Medical Systems, Inc. KRMD NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
62/100
4/7 Pass
SharesGrow Intrinsic Value
$12.49
+190.5%
Analyst Price Target
$7.00
+62.8%

KORU Medical Systems, Inc. (KRMD) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $4.30. It has a SharesGrow Score of 62/100, indicating a above average investment profile with 4 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of KRMD = $12.49 (+190.5% from the current price, the stock appears undervalued). Analyst consensus target is KRMD = $7 (+62.8% upside).

Valuation: KRMD trades at a trailing Price-to-Earnings (P/E) of -72.5 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.37.

Financials: revenue is $41M, +14.1%/yr average growth. Net income is $3M (loss), growing at +17.9%/yr. Net profit margin is -6.4% (negative). Gross margin is 60.3% (+5.2 pp trend).

Balance sheet: total debt is $3M against $17M equity (Debt-to-Equity (D/E) ratio 0.21, conservative). Current ratio is 2.44 (strong liquidity). Debt-to-assets is 12.4%. Total assets: $28M.

Analyst outlook: 4 / 5 analysts rate KRMD as buy (80%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 80/100 (Pass), Past 0/100 (Fail), Health 100/100 (Pass), Moat 50/100 (Partial), Future 94/100 (Pass), Income 10/100 (Fail).

$7.00
▲ 62.79% Upside
Average Price Target
Based on 5 Wall Street analysts offering 12-month price targets for KORU Medical Systems, Inc., the average price target is $7.00, with a high forecast of $8.00, and a low forecast of $6.00.
Highest Price Target
$8.00
Average Price Target
$7.00
Lowest Price Target
$6.00

KRMD SharesGrow Score Overview

72/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 100/100
Valuation — P/E, PEG, Forward PEG
GROWTH 80/100
Financials — average growth
PAST 0/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 50/100
Gross margin is + market cap
FUTURE 94/100
Analyst outlook — as buy
INCOME 10/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Stock Chart & Stats

Market Data
52-Week Range1.86-6.608
Volume91.33K
Avg Volume (30D)194.75K
Market Cap$199.39M
Beta (1Y)0.54
Share Statistics
EPS (TTM)-0.06
Shares Outstanding$46.19M
IPO Date1994-04-05
Employees80
CEOLinda Tharby
Financial Highlights & Ratios
Revenue (TTM)$41.13M
Gross Profit$24.79M
EBITDA$-2.16M
Net Income$-2.64M
Operating Income$-2.97M
Total Cash$8.87M
Total Debt$3.5M
Net Debt$-5.38M
Total Assets$28.2M
Price / Earnings (P/E)-75.3
Price / Sales (P/S)4.85
Analyst Forecast
1Y Price Target$7.00
Target High$8.00
Target Low$6.00
Upside+62.8%
Rating ConsensusBuy
Analysts Covering5
Buy 80% Hold 20% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS7599101026

Price Chart

KRMD
KORU Medical Systems, Inc.  ·  NASDAQ Capital Marke
Healthcare • Medical - Instruments & Supplies
1.86 52WK RANGE 6.61
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message